Gastroesophageal Reflux Disease
📧 Sign up to get email alerts when something new happens for Gastroesophageal Reflux Disease.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2011-01-24Clinical Trial Update: Esomeprazole for Relief of Upper Gastrointestinal Symptoms Associated With Continuous Use of NSAIDs [Phase 3]
A Phase 3 trial evaluating esomeprazole for relief of NSAID-associated upper gastrointestinal symptoms in GERD patients has completed.
-
CLINICAL_TRIALS trial_result · 2011-01-24Clinical Trial Update: Chest Pain Pilot Study [Phase 3]
Phase 3 chest pain and gastroesophageal reflux disease trial has completed.
-
CLINICAL_TRIALS trial_result · 2011-01-24Clinical Trial Update: Sopran - Omeprazole Treatment Versus Surgery [Phase 3]
Phase 3 trial comparing omeprazole treatment with surgery for gastroesophageal reflux disease has completed.
-
CLINICAL_TRIALS trial_result · 2011-01-24Clinical Trial Update: Open, Randomized, Two Way Crossover Study Comparing the Effect of Esomeprazole Adminstered Orally and iv [Phase 4]
Phase 4 open-label, randomized two-way crossover trial comparing oral and intravenous esomeprazole for Gastroesophageal reflux disease has b…
-
CLINICAL_TRIALS trial_result · 2011-01-24Clinical Trial Update: A Study of Cisapride in Patients With Symptomatic Gastro-Oesophageal Reflux Disease [Phase 4]
A Phase 4 study of cisapride in patients with gastroesophageal reflux disease has been terminated.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2011-01-24Clinical Trial Update: Study Comparing the Effects of Esomeprazole Adminstered Orally and Intravenously on Basal and Pentrigastrin-stimulated Acid Output in Subjects With Symptoms of Gastroesophageal Reflux Disease (GERD) [Phase 4]
Phase 4 clinical trial comparing oral and intravenous esomeprazole on basal and pentagastrin-stimulated acid output in subjects with gastroe…
-
CLINICAL_TRIALS trial_result · 2011-01-24Clinical Trial Update: Symptom Adapted Therapy in GERD Patients [Phase 4]
This entry reports a completed Phase 4 clinical trial on symptom-adapted therapy for gastroesophageal reflux disease.
-
CLINICAL_TRIALS trial_result · 2011-01-21Clinical Trial Update: Esomeprazole for Prevention of Upper Gastrointestinal Symptoms Associated With Continuous Use of NSAIDs [Phase 3]
This update notes the completion of a Phase 3 trial evaluating esomeprazole to prevent upper gastrointestinal symptoms in patients continuou…
-
CLINICAL_TRIALS trial_result · 2011-01-21Clinical Trial Update: Study Comparing Esomeprazole Magnesium 40mg Once Daily Versus Lansoprazole 30 mg Twice Daily in Symptom Control of Subjects With Persistent Gastrooesophageal Reflux Disease (GERD) [Phase 4]
Phase 4 clinical trial comparing esomeprazole magnesium 40 mg daily with lansoprazole 30 mg twice daily for symptom control in persistent ga…
-
FDA approval · 2011-01-20FDA Approved: PANTOPRAZOLE SODIUM — Original Application (Lannett Company, Inc.)
FDA approved Lannett Company's original Abbreviated New Drug Application for pantoprazole sodium, enabling a generic pantoprazole product. T…
-
FDA approval · 2011-01-19FDA Approved: PANTOPRAZOLE — Original Application (NorthStar RxLLC)
FDA approved the original application for pantoprazole submitted by NorthStar RxLLC, launching a generic pantoprazole product.
-
FDA approval · 2011-01-19FDA Approved: PANTOPRAZOLE SODIUM — Original Application (Torrent Pharmaceuticals Limited)
FDA approved Pantoprazole sodium from Torrent Pharmaceuticals Limited under an original ANDA; a generic version of pantoprazole for conditio…
-
FDA approval · 2011-01-19FDA Approved: PANTOPRAZOLE SODIUM — Original Application (Mylan Pharmaceuticals Inc.)
FDA approved the original ANDA for pantoprazole sodium, a generic proton pump inhibitor manufactured by Mylan Pharmaceuticals. This approval…
-
CLINICAL_TRIALS trial_result · 2011-01-11Clinical Trial Update: Non-interventional Study to Evaluate the Change in Symptoms Scores and Treatment Response After 4 Weeks of Proton-Pump Inhibitors (PPI) Treatment
A non-interventional study completed to evaluate changes in symptom scores and treatment response after 4 weeks of proton-pump inhibitor the…
-
CLINICAL_TRIALS trial_result · 2011-01-10Clinical Trial Update: A Pharmacokinetic and Safety Study of Single and Multiple Doses of Rabreprazole in Pediatric Patients With Gastroesophageal Reflux Disease (GERD) 1 to 11 Years Old, Inclusive [Phase 1]
A Phase 1 pharmacokinetic and safety study evaluated single and multiple doses of rabreprazole in children aged 1 to 11 with gastroesophagea…
-
FDA approval · 2011-01-07FDA Approved: OMEPRAZOLE — Supplemental Application (Sandoz Inc)
The FDA approved a supplemental application for omeprazole from Sandoz Inc., granting an additional approval under the ANDA for the generic …
-
FDA approval · 2011-01-06FDA Approved: FAMOTIDINE — Supplemental Application (Baxter Healthcare Corporation)
FDA approved a supplemental application for famotidine submitted by Baxter Healthcare Corporation, resulting in a label change for the produ…
-
FDA approval · 2010-12-20FDA Approved: PRILOSEC OTC — Supplemental Application (The Procter & Gamble Manufacturing Company)
FDA approved a supplemental application for PRILOSEC OTC (omeprazole magnesium) submitted by The Procter & Gamble Manufacturing Company.
-
CLINICAL_TRIALS research · 2010-12-13Clinical Trial Update: Symptom Assessment for GERD Patients Receiving H. Pylori Eradication
This entry reports a clinical trial update on symptom assessment for Gastroesophageal Reflux Disease patients receiving Helicobacter pylori …
-
CLINICAL_TRIALS trial_result · 2010-12-07Clinical Trial Update: 14473 - D9126C00001 Proof of Principle Study - Effect of AZD2066 on Transient Lower Esophageal Sphincter Relaxations [Phase 1, Phase 2]
This is a completed Phase 1/2 proof-of-principle trial evaluating AZD2066 for reducing transient lower esophageal sphincter relaxations in p…
-
CLINICAL_TRIALS trial_result · 2010-12-07Clinical Trial Update: AZD3355 Dose-escalation Study in Healthy Males [Phase 1]
Phase 1 dose-escalation trial of AZD3355 in healthy male volunteers completed, evaluating safety, tolerability, and pharmacokinetics in the …
-
CLINICAL_TRIALS trial_result · 2010-12-07Clinical Trial Update: Structured Treatment of Gastroesophageal Reflux in a Company Health Care Setting, -Effect on Quality of Life, Symptoms and Productivity
This completed AstraZeneca-sponsored trial evaluated a structured treatment approach for gastroesophageal reflux disease in a corporate heal…
-
CLINICAL_TRIALS research · 2010-12-07Clinical Trial Update: Symptoms and Management Strategies in Gastroesophageal Reflux Disease (GERD)
This document reports a completed AstraZeneca-sponsored clinical trial focused on symptoms and management strategies in gastroesophageal ref…
-
CLINICAL_TRIALS trial_result · 2010-12-07Clinical Trial Update: Prevalence of EED and Quality of Life Evaluated by Gastroesophageal Reflux Disease (GERD)-Q in Korean GERD Patients
A completed AstraZeneca-sponsored clinical trial in Korean patients with gastroesophageal reflux disease evaluating the prevalence of erosiv…
-
CLINICAL_TRIALS research · 2010-12-07Clinical Trial Update: The Clinical Significance of Minimal Change in Reflux Esophagitis Based on the Gastroesophageal Reflux Disease Questionnaire
A completed AstraZeneca-sponsored study evaluating the clinical significance of minimal changes in reflux esophagitis as measured by the Gas…